Absorption and subcellular localization of lycopene in human prostate cancer cells

Molecular Cancer Therapeutics

Volumn 5, Issue 11, 2006, Pages 2879-2885

  Liu, Ang ^a   Pajkovic, Natasa ^a   Pang, Yan ^a   Zhu, Dongwei ^a   Calamini, Barbara ^a   Mesacar, Andrew L ^a   van Breemen, Richard B ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; LYCOPENE; PROSTATE SPECIFIC ANTIGEN;

ABSORPTION; ANTIGEN EXPRESSION; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER PREVENTION; CELL FRACTIONATION; CELL NUCLEUS MATRIX; CELL NUCLEUS MEMBRANE; CELL STRAIN LNCAP; CELLULAR DISTRIBUTION; CENTRIFUGATION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; INCUBATION TIME; LIGAND BINDING; LIQUID CHROMATOGRAPHY; MALE; MICROSOME; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

ANTICARCINOGENIC AGENTS; BINDING SITES; CAROTENOIDS; CELL NUCLEUS; CHROMATOGRAPHY, LIQUID; HUMANS; KINETICS; MALE; MASS SPECTROMETRY; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 33845230150     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-06-0373     Document Type: Article

References (37)

1. Cancer trends progress report - 2005 update. National Cancer Institute, NIH, DHHS, Bethesda, MD. 2005 December.
2. Hadley CW, Miller EC, Schwartz SJ, Clinton SK. Tomatoes, lycopene, and prostate cancer: Progress and promise. Exp Biol Med (Maywood) 2002;227:869-80.
3. Chan JM, Gann PH, Giovannucci EL. Role of diet in prostate cancer development and progression. J Clin Oncol 2005;23:8152-60.
4. Cook LS, Goldoft M, Schwartz SM, Weiss NS. Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J Urol 1999;161:152-5.
5. Klein EA. Chemoprevention of prostate cancer. Annu Rev Med 2006; 57:49-63.
6. Pathak SK, Sharma RA, Mellon JK. Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation [review]. Int J Oncol 2003;22:5-13.
7. Kucuk O. Chemoprevention of prostate cancer. Cancer Metastasis Rev 2002;21:111-24.
8. Xu X, Wang Y, Constantinou AI, Stacewicz-Sapuntzakis M, Bowen PE, van Breemen RB. Solubilization and stabilization of carotenoids using micelles: delivery of lycopene to cells in culture. Lipids 1999;34: 1031-6.
9. Hwang ES, Bowen PE. Cell cycle arrest and induction of apoptosis by lycopene in LNCaP human prostate cancer cells. J Med Food 2004;7: 284-9.
10. Khachik F, Carvalho L, Bernstein PS, Muir GJ, Zhao DY, Katz NB. Chemistry, distribution, and metabolism of tomato carotenoids and their impact on human health. Exp Biol Med (Maywood) 2002;227: 845-51.
11. Ford ES. Variations in serum carotenoid concentrations among United States adults by ethnicity and sex. Ethn Dis 2000;10:208-17.
12. Mayne ST, Cartmel B, Silva F, et al. Plasma lycopene concentrations in humans are determined by lycopene intake, plasma cholesterol concentrations and selected demographic factors. J Nutr 1999;129: 849-54.
13. Rao AV, Agarwal S. Role of antioxidant lycopene in cancer and heart disease. J Am Coll Nutr 2000;19:563-9.
14. Kotake-Nara E, Kushiro M, Zhang H, Sugawara T, Miyashita K, Nagao A. Carotenoids affect proliferation of human prostate cancer cells. J Nutr 2001;131:3303-6.
15. Siler U, Barella L, Spitzer V, et al. Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model. FASEB J 2004;18:1019-21.
16. Chen L, Stacewicz-Sapuntzakis M, Duncan C, et al. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst 2001;93: 1872-9.
17. Kucuk O, Sarkar FH, Sakr W, et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 2001;10:861-8.
18. Giovannucci E. Tomato products, lycopene, and prostate cancer: a review of the epidemiological literature. J Nutr 2005;135:2030-15.
19. Gann PH, Ma J, Giovennucci E, et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 1999;59:1225-30.
20. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995;87:1767-76.
21. Agarwal S, Rao AV. Carotenoids and chronic diseases. Drug Metabol Drug Interact 2000;17:189-210.
22. Livny O, Kaplan I, Reifen R, Polak-Charcon S, Madar Z, Schwartz B. Lycopene inhibits proliferation and enhances gap-junction communication of KB-1 human oral tumor cells. J Nutr 2002;132:3754-9.
23. Mucci LA, Tamimi R, Lagiou P, et al. Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system? BJU Int 2001;87:814-20.
24. Fang L, Pajkovic N, Wang Y, Gu C, van Breemen RB. Quantitative analysis of lycopene isomers in human plasma using high-performance liquid chromatography-tandem mass spectrometry. Anal Chem 2003;75: 812-7.
25. van Breemen RB, Xu X, Viana MA, et al. Liquid chromatography-mass spectrometry of cis- and all trans-lycopene in human serum and prostate tissue after dietary supplementation with tomato sauce. J Agric Food Chem 2002;50:2214-9.
26. Bonifacino JS, Dasso M, Harford JB, Lippincott-Schwartz J, Yamada KM. Short protocols in cell biology: a compendium of methods from current protocols in cell biology. Hoboken (New Jersey): John Wiley; 2004.
27. Rosenberg IM. Protein analysis and purification: benchtop techniques. Boston: Birkhäuser; 1996.
28. Zhao XY, Malloy PF, Krishnan AV, Navone NM, Peehl DM, Feldman D. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor. Nat Med 2000;6: 703-6.
29. ccr) derived from an androgen-independent prostate cancer. J Med Chem 2002;45:1439-46.
30. Sun Y, Gu C, Liu X, et al. Ultrafiltration tandem mass spectrometry of estrogens for characterization of structure and affinity for human estrogen receptors. J Am Soc Mass Spectrom 2005;16:271-9.
31. Freeman VL, Meydani M, Yong S, et al. Prostatic levels of tocopherols, carotenoids, and retinol in relation to plasma levels and self-reported usual dietary intake. Am J Epidemiol 2000;151:109-18.
32. Ferreira AL, Yeum KJ, Liu C, et al. Tissue distribution of lycopene in ferrets and rats after lycopene supplementation. J Nutr 2000;130: 1256-60.
33. van Breemen RB. How do intermediate endpoint markers respond to lycopene in men with prostate cancer or benign prostate hyperplasia? J Nutr 2005;135:2062-64S.
34. Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989;274:532-8.
35. Hwang ES, Bowen PE. Effects of lycopene and tomato paste extracts on DNA and lipid oxidation in LNCaP human prostate cancer cells. Biofactors 2005;23:97-105.
36. Wertz K, Siler U, Goralczyk R. Lycopene: Modes of action to promote prostate health. Arch Biochem Biophys 2004;430:127-34.
37. Djavan B, Zlotta A, Schulman C, et al. Chemotherapeutic prevention studies of prostate cancer. J Urol 2004;171:S10-3; discussion S13-4.